Cardiovascular changes in IUGR

Giancarlo Mari, Brian Brocato, Roopali V. Donepudi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Despite a plethora of publications existing in the literature, there is still confusion about the definition and management of intrauterine growth-restricted fetuses. A second source of confusion lies in the fundamental misunderstanding that all growth-restricted fetuses are the same and all will progress to cardiovascular failure following a similar time frame. Once intrauterine growth restriction is identified, obstetrical management is focused on assuring safety while the fetus continues to mature within a potentially hostile intrauterine environment. In the United States, the approach to management and delivery of the premature growth-restricted fetus is often based on serial biophysical profile evaluations, whereas in Europe it is usually based on the result of the cardiotocography. However, there is no single test that seems superior to the other available tests for timing the delivery of the growth-restricted fetus. Therefore, the decision to deliver a fetus, especially at <32 weeks, remains mostly on the basis of empirical management. The staging system may allow comparison of outcome data for IUGR fetuses and may be valuable in determining more timely delivery for these high-risk fetuses. Most investigators agree that Doppler ultrasonography of the umbilical artery and the middle cerebral arteries, in combination with biometry provides the best tool to identify small fetuses at risk for adverse outcomes. The umbilical artery and the middle cerebral artery are the two vessels that have been extensively studied. Recent studies have looked into the analysis of the fetal venous system and the association between changes in this system with the fetal outcome.

Original languageEnglish (US)
Title of host publicationHandbook of Growth and Growth Monitoring in Health and Disease
PublisherSpringer New York
Pages275-297
Number of pages23
ISBN (Electronic)9781441917959
ISBN (Print)9781441917942
DOIs
StatePublished - Jan 1 2012

Fingerprint

Fetal Growth Retardation
Fetus
Growth
Umbilical Arteries
Middle Cerebral Artery
Cardiotocography
Biometry
Doppler Ultrasonography
Publications
Research Personnel
Safety

All Science Journal Classification (ASJC) codes

  • Nursing(all)

Cite this

Mari, G., Brocato, B., & Donepudi, R. V. (2012). Cardiovascular changes in IUGR. In Handbook of Growth and Growth Monitoring in Health and Disease (pp. 275-297). Springer New York. https://doi.org/10.1007/978-1-4419-1795-9_17

Cardiovascular changes in IUGR. / Mari, Giancarlo; Brocato, Brian; Donepudi, Roopali V.

Handbook of Growth and Growth Monitoring in Health and Disease. Springer New York, 2012. p. 275-297.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mari, G, Brocato, B & Donepudi, RV 2012, Cardiovascular changes in IUGR. in Handbook of Growth and Growth Monitoring in Health and Disease. Springer New York, pp. 275-297. https://doi.org/10.1007/978-1-4419-1795-9_17
Mari G, Brocato B, Donepudi RV. Cardiovascular changes in IUGR. In Handbook of Growth and Growth Monitoring in Health and Disease. Springer New York. 2012. p. 275-297 https://doi.org/10.1007/978-1-4419-1795-9_17
Mari, Giancarlo ; Brocato, Brian ; Donepudi, Roopali V. / Cardiovascular changes in IUGR. Handbook of Growth and Growth Monitoring in Health and Disease. Springer New York, 2012. pp. 275-297
@inbook{27de808c97f64f3496b296964bdbc060,
title = "Cardiovascular changes in IUGR",
abstract = "Despite a plethora of publications existing in the literature, there is still confusion about the definition and management of intrauterine growth-restricted fetuses. A second source of confusion lies in the fundamental misunderstanding that all growth-restricted fetuses are the same and all will progress to cardiovascular failure following a similar time frame. Once intrauterine growth restriction is identified, obstetrical management is focused on assuring safety while the fetus continues to mature within a potentially hostile intrauterine environment. In the United States, the approach to management and delivery of the premature growth-restricted fetus is often based on serial biophysical profile evaluations, whereas in Europe it is usually based on the result of the cardiotocography. However, there is no single test that seems superior to the other available tests for timing the delivery of the growth-restricted fetus. Therefore, the decision to deliver a fetus, especially at <32 weeks, remains mostly on the basis of empirical management. The staging system may allow comparison of outcome data for IUGR fetuses and may be valuable in determining more timely delivery for these high-risk fetuses. Most investigators agree that Doppler ultrasonography of the umbilical artery and the middle cerebral arteries, in combination with biometry provides the best tool to identify small fetuses at risk for adverse outcomes. The umbilical artery and the middle cerebral artery are the two vessels that have been extensively studied. Recent studies have looked into the analysis of the fetal venous system and the association between changes in this system with the fetal outcome.",
author = "Giancarlo Mari and Brian Brocato and Donepudi, {Roopali V.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-1-4419-1795-9_17",
language = "English (US)",
isbn = "9781441917942",
pages = "275--297",
booktitle = "Handbook of Growth and Growth Monitoring in Health and Disease",
publisher = "Springer New York",
address = "United States",

}

TY - CHAP

T1 - Cardiovascular changes in IUGR

AU - Mari, Giancarlo

AU - Brocato, Brian

AU - Donepudi, Roopali V.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Despite a plethora of publications existing in the literature, there is still confusion about the definition and management of intrauterine growth-restricted fetuses. A second source of confusion lies in the fundamental misunderstanding that all growth-restricted fetuses are the same and all will progress to cardiovascular failure following a similar time frame. Once intrauterine growth restriction is identified, obstetrical management is focused on assuring safety while the fetus continues to mature within a potentially hostile intrauterine environment. In the United States, the approach to management and delivery of the premature growth-restricted fetus is often based on serial biophysical profile evaluations, whereas in Europe it is usually based on the result of the cardiotocography. However, there is no single test that seems superior to the other available tests for timing the delivery of the growth-restricted fetus. Therefore, the decision to deliver a fetus, especially at <32 weeks, remains mostly on the basis of empirical management. The staging system may allow comparison of outcome data for IUGR fetuses and may be valuable in determining more timely delivery for these high-risk fetuses. Most investigators agree that Doppler ultrasonography of the umbilical artery and the middle cerebral arteries, in combination with biometry provides the best tool to identify small fetuses at risk for adverse outcomes. The umbilical artery and the middle cerebral artery are the two vessels that have been extensively studied. Recent studies have looked into the analysis of the fetal venous system and the association between changes in this system with the fetal outcome.

AB - Despite a plethora of publications existing in the literature, there is still confusion about the definition and management of intrauterine growth-restricted fetuses. A second source of confusion lies in the fundamental misunderstanding that all growth-restricted fetuses are the same and all will progress to cardiovascular failure following a similar time frame. Once intrauterine growth restriction is identified, obstetrical management is focused on assuring safety while the fetus continues to mature within a potentially hostile intrauterine environment. In the United States, the approach to management and delivery of the premature growth-restricted fetus is often based on serial biophysical profile evaluations, whereas in Europe it is usually based on the result of the cardiotocography. However, there is no single test that seems superior to the other available tests for timing the delivery of the growth-restricted fetus. Therefore, the decision to deliver a fetus, especially at <32 weeks, remains mostly on the basis of empirical management. The staging system may allow comparison of outcome data for IUGR fetuses and may be valuable in determining more timely delivery for these high-risk fetuses. Most investigators agree that Doppler ultrasonography of the umbilical artery and the middle cerebral arteries, in combination with biometry provides the best tool to identify small fetuses at risk for adverse outcomes. The umbilical artery and the middle cerebral artery are the two vessels that have been extensively studied. Recent studies have looked into the analysis of the fetal venous system and the association between changes in this system with the fetal outcome.

UR - http://www.scopus.com/inward/record.url?scp=85025605662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025605662&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-1795-9_17

DO - 10.1007/978-1-4419-1795-9_17

M3 - Chapter

SN - 9781441917942

SP - 275

EP - 297

BT - Handbook of Growth and Growth Monitoring in Health and Disease

PB - Springer New York

ER -